MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma - Kang, E.Y.; Millstein, J.; Popovic, G.; Meagher, N.S.; Bolithon, A.; Talhouk, A.; Chiu, D.S.; Anglesio, M.S.; Leung, B.; Tang, K.; Lambie, N.; Pavanello, M.; et al. (Virchows Archiv, 2022)